Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 28 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

7%

2 trials in Phase 3/4

Results Transparency

0%

0 of 8 completed trials have results

Key Signals

9 recruiting

Enrollment Performance

Analytics

N/A
10(47.6%)
Phase 1
7(33.3%)
Early Phase 1
2(9.5%)
Phase 4
2(9.5%)
21Total
N/A(10)
Phase 1(7)
Early Phase 1(2)
Phase 4(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (28)

Showing 20 of 28 trials
NCT07494799Not Yet Recruiting

Efficacy of Different Interventions for Progressive Myopia After Orthokeratology Lens Wear

Role: lead

NCT07449247Phase 1Not Yet Recruiting

PROTECT-Study: Prospective Research on Optimizing Atropine Concentration Escalation for Children's Myopia Prevention

Role: lead

NCT07186088Not ApplicableNot Yet Recruiting

Therapeutic Efficacy of Different Repeated Low-Intensity Red Light Devices and Different Usage Frequencies

Role: collaborator

NCT07160036Not ApplicableRecruiting

Repeatability of AO-SLO (Mona IIa) Technology and Cone Cell Density of Individuals Use Repeated Low-level Red-light Therapy

Role: collaborator

NCT06672536Phase 1Recruiting

Multicenter, Phase I/II Study to Evaluate the Safety, Tolerability, PK and Efficacy of SCT520FF in Patients With nAMD

Role: collaborator

NCT07119723Enrolling By Invitation

Environmental Factors and Myopia Prevalence Among Uyghur Students in Remote China

Role: lead

NCT07106268Active Not Recruiting

Aqueous Humor Proteome in Retinal Vein Occlusion With Macular Edema

Role: lead

NCT06031727Early Phase 1Recruiting

CRISPR/cas13-medIated RNA TarGeting THerapy for the Treatment of Neovascular Age-related Macular Degeneration Investigator-initiated Trial (SIGHT-I)

Role: collaborator

NCT06667037Not ApplicableRecruiting

Orthokeratology and 0.01% Atropine Sequential Treatment for Myopia Control

Role: collaborator

NCT04016675Not ApplicableRecruiting

Neoadjuvant Radiotherapy for Malignant Lacrimal Sac Tumors

Role: collaborator

NCT06478407Recruiting

Community Screening Study of Diabetic Retinopathy in Tianjin in 2024

Role: collaborator

NCT06492863Phase 1Recruiting

Gene Therapy(FT-003) for Wet AMD

Role: collaborator

NCT05728476Not ApplicableRecruiting

Microinvasive Pars Plana Vitrectomy Combined ILM Peeling Versus Anti-VEGF Intravitreal Injection for Treatment-naïve Diabetic Macular Edema

Role: lead

NCT05990829Phase 4Unknown

Compare the Efficacy of VItrectomy Combined With DExamethasone Implant Versus With Aflibercept in DME Patients Diagnosed by Intraoperative OCT (the VIDEO Study): Study Protocol for a Randomized Controlled Trial

Role: lead

NCT06175676Phase 1Completed

Safety and Efficacy of Thermosensitive Hydroxybutyl Chitosan and 5-fluorouracil Assisted Endoscopic Dacryocystorhinostomy in the Treatment of Chronic Dacryocystitis

Role: lead

NCT05916391Phase 1Recruiting

Gene Therapy for Diabetic Macular Edema

Role: collaborator

NCT05446948Not ApplicableCompleted

Observation of the Efficacy of Different Vitrectomy Systems to Treat Proliferative Diabetic Retinopathy

Role: lead

NCT05611424Phase 1Not Yet Recruiting

Gene Therapy for Wet AMD

Role: collaborator

NCT05771194Phase 4Completed

Analysis of Postoperative Ocular Surface Changes and Intervention Effect After PPV in MGD Dry Eye Patients

Role: lead

NCT05757349Not ApplicableUnknown

Analysis of Novel Positioning Sensor-assisted Postoperative Position Correction and Effective Prone Time Recorded in Patients With Different Prone Times After Macular Hole Surgery

Role: lead